Future #1
Photoperiod indica-dominant hybrid with minimal independent verification beyond vendor claims.
Growing, buying or possessing cannabis and seeds is legal only in some places. Check the law where you live before acting on this information.
Future #1 exists as a commercial seed offering, but nearly all specific claims — THC %, terpenes, effects, parentage — come from the people selling it. There are no peer-reviewed studies, no regulatory lab tests, no genetic databases listing it. That doesn't mean it's fake; it means you're buying on faith. If you grow it, your phenotype and a real lab test will teach you more than any product description.
Overview
Future #1 is a photoperiod cannabis cultivar marketed as an indica-dominant hybrid, available through seed banks including Weedseedsexpress and documented on Leafly. Weak / limited
Outside of vendor product pages and reseller blogs, there is essentially no independent documentation of the strain — no peer-reviewed chemical analyses, no entries in major academic strain genetics databases, and no regulatory cannabinoid testing records publicly available. No data
That does not mean the strain doesn't exist or isn't worth growing. It does mean that nearly every specific claim about Future #1 — its THC content, terpene profile, effects, and parentage — originates from the people selling the seeds. Readers should weigh that accordingly.
Chemistry
Vendor listings give Future #1 a THC content in the low-to-mid 20s percent and a CBD content under 1%. We have not found independent certificates of analysis (COA) to verify these numbers. No data
No dominant terpene profile is consistently named across vendor sources. Some descriptions mention earthy, pine, and diesel notes, but no gas chromatography–mass spectrometry (GC-MS) terpene panel for this specific cultivar is publicly available. No data
Cannabinoid and terpene content within a single named strain varies widely between phenotypes, grows, and labs — even for well-studied cultivars [1][2]. A single percentage number for any strain is best read as a marketing estimate, not a specification. Strong evidence
Reported effects
Vendor and reseller descriptions of Future #1 emphasize a heavy, relaxing, body-forward experience typical of indica-leaning marketing copy. Anecdote
There are no clinical trials, observational studies, or controlled human research on Future #1 specifically, and no published peer-reviewed studies on this strain exist in the scientific literature. Any claims about it helping with sleep, pain, stress, or appetite are extrapolated from general cannabis pharmacology, not from research on Future #1.
It is also important to note that the long-standing 'indica = sedating, sativa = energizing' framework is not supported by chemistry. A 2015 analysis found that indica/sativa labels poorly predict cannabinoid and terpene content [3], and chemovar-based (chemical profile) classifications are now considered more useful than the indica/sativa binary [4]. Strong evidence So 'indica-dominant hybrid' on a product label tells you something about expected plant morphology and vendor positioning — not reliably about subjective effects.
Lineage
Some vendor descriptions associate Future #1 with the Gorilla Glue / GG4 lineage, but we have not found a breeder statement with verifiable provenance — for example, a documented seed-bank release note, a breeder interview, or any cross record that confirms specific parents. Disputed
This is common in modern cannabis: most strain pedigrees on the market are unverifiable claims, and genetic studies have repeatedly shown that strain names are not reliable indicators of actual genetic relationships [5]. Strong evidence Until a breeder publishes a sourced lineage or someone runs a genetic comparison, Future #1's parentage should be treated as unconfirmed.
Cultivation basics
Per vendor information, Future #1 is a photoperiod strain with a flowering window around 8–9 weeks indoors and a reported indoor yield in the ~450–550 g/m² range under good conditions. It is described as forgiving for beginners and responsive to standard indica-style training (topping, low-stress training, SCROG).
General cultivation guidance for any indica-leaning photoperiod hybrid applies:
- Photoperiod: 18/6 light hours in vegetative growth; switch to 12/12 to trigger flowering.
- Lighting: Moderate to high light intensity; modern LEDs in the 600–900 µmol/m²/s PPFD range during flower are typical for high-yield indoor grows [6]. Strong evidence
- Environment: Watch for dense, resinous buds that can trap moisture late in flower — airflow and humidity control reduce botrytis (bud rot) risk.
Because there is no independent grower documentation specific to Future #1, expect to dial in your own phenotype rather than rely on a detailed 'recipe.'
Marketing vs. reality
Here is the candid summary:
- What is real: Future #1 is a strain you can buy seeds of from at least one established seed bank, with typical photoperiod hybrid characteristics listed on product pages. Weak / limited
- What is marketing: The specific THC percentage, the implied Gorilla Glue lineage, the predicted effects, and the 'easy to grow' framing are vendor claims, not independently verified facts. Weak / limited
- What is folklore: Any suggestion that being 'indica-dominant' tells you how Future #1 will feel relies on a category that doesn't hold up to chemical analysis. See The Indica/Sativa Myth. Strong evidence
If you grow Future #1, you will learn more from your own phenotype observations and (ideally) a lab test of the dried flower than from any product description — including this one.
Frequently asked questions
Is Future #1 indica or sativa?
It is sold as 'indica-dominant hybrid.' However, the indica/sativa classification does not reliably predict effects or chemistry. Strong evidence
How much THC does Future #1 have?
Vendors list it at 20–22% THC, but no independent lab certificate of analysis is publicly available. Weak / limited If you grow or buy dried flower, ask the seller for a third-party COA to verify the actual content.
How long does Future #1 take to flower?
Vendor listings report 8–9 weeks under a 12/12 photoperiod indoors. Actual flowering time varies with genetics, phenotype, light intensity, temperature, and nutrients. Weak / limited
Who bred Future #1?
Breeder identity is not clearly stated in publicly available vendor or media sources. Some descriptions suggest a connection to Gorilla Glue genetics, but this is not confirmed by documented lineage. Disputed
Sources
- Peer-reviewed Jikomes N, Zoorob M. The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products. Scientific Reports. 2018;8:4519.
- Peer-reviewed Smith CJ, Vergara D, Keegan B, Jikomes N. The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE. 2022;17(5):e0267498.
- Peer-reviewed Elzinga S, Fischedick J, Podkolinski R, Raber JC. Cannabinoids and Terpenes as Chemotaxonomic Markers in Cannabis. Natural Products Chemistry & Research. 2015;3:181.
- Peer-reviewed Hazekamp A, Tejkalová K, Papadimitriou S. Cannabis: From Cultivar to Chemovar II—A Metabolomics Approach to Cannabis Classification. Cannabis and Cannabinoid Research. 2016;1(1):202–215.
- Peer-reviewed Sawler J, Stout JM, Gardner KM, et al. The Genetic Structure of Marijuana and Hemp. PLOS ONE. 2015;10(8):e0133292.
- Peer-reviewed Chandra S, Lata H, Khan IA, ElSohly MA. Photosynthetic response of Cannabis sativa L. to variations in photosynthetic photon flux densities, temperature and CO2 conditions. Physiology and Molecular Biology of Plants. 2008;14(4):299–306.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Certificate of Analysis (COA) — Lab-issued document reporting cannabinoid potency and contaminant screening for a specific...
- Gelonade — Connected Cannabis hybrid known for citrus aroma and balanced effects.
- The Indica/Sativa Myth — The popular classification system contradicts genetics, chemistry, and controlled research...